Senior insider sale
Chief Development Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$142.8K
12.66K shares
What this filing means
KAISER PETER plans to sell 12.66K shares of OCULAR THERAPEUTIX, INC valued at approximately $142.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/2/2025ACC: 0001950047-25-007693
Officer· Chief Development Officer
Since Feb 2026
12.66K
Shares to sell
$142.8K
Approx. market value
9.65K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
10/1/2025
9.65KTotal acquired9.65K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2025 | Restricted stock vesting under a registered plan Not Applicable | 9.65K | — |
| Total | 9.65K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.01K
Market value
$36.3K
8/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.65K
Market value
$106.5K
10/2/2025
Total
Units
12.66K
Value
$142.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/25/2025 | 3.01K | $36.3K | — | Completed |
| Planned — Approximate Date | ||||
10/2/2025 | 9.65K | $106.5K | NASDAQ | Planned |
| Total | 12.66K | $142.8K | ||